BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1934983)

  • 1. Aspirin, salicylates, and nonsteroidal anti-inflammatory drugs: new class labeling and medical practice.
    Roth SH
    Compr Ther; 1991 Jun; 17(6):15-21. PubMed ID: 1934983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiphlogistic effect of salicylic acid and its derivatives].
    Binder M; Zeiller P
    Fortschr Med; 1993 Nov; 111(33):530-2. PubMed ID: 8307537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: recommendation statement.
    Am Fam Physician; 2007 Jul; 76(1):109-13. PubMed ID: 17668849
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract.
    Raithel M; Baenkler HW; Naegel A; Buchwald F; Schultis HW; Backhaus B; Kimpel S; Koch H; Mach K; Hahn EG; Konturek PC
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():89-102. PubMed ID: 16247191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule; technical amendments.
    Fed Regist; 1999 Sep; 64(177):49652-5. PubMed ID: 10915461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Fries JF
    N Engl J Med; 1999 Oct; 341(18):1397-8; author reply 1398-9. PubMed ID: 10577092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation between the administration of salicylates in various viral infections and the appearance of Reye's syndrome].
    Velásquez Jones L
    Bol Med Hosp Infant Mex; 1982 Jun; 39(6):395-7. PubMed ID: 6981418
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
    ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Harewood G
    N Engl J Med; 1999 Oct; 341(18):1398; author reply 1398-9. PubMed ID: 10577093
    [No Abstract]   [Full Text] [Related]  

  • 12. Diflunisal -- a new analgesic.
    Huskisson EC
    Practitioner; 1979 Mar; 222(1329):415-8. PubMed ID: 377268
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects of non-steroidal antirheumatic drugs with special reference to the gastrointestinal tract].
    Hackenthal E
    Z Rheumatol; 1987; 46 Suppl 1():83-8. PubMed ID: 3439373
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and salicylate in respiratory disease.
    Mitchell JE; Skypala I
    Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk.
    U.S. Food and Drug Administration
    J Pain Palliat Care Pharmacother; 2005; 19(4):83-97. PubMed ID: 16431839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2007 Mar; 146(5):361-4. PubMed ID: 17339621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.